1.875
price up icon13.11%   0.235
 
loading

Invivyd Inc (IVVD) 最新ニュース

pulisher
07:50 AM

What’s the recovery path for long term holders of Invivyd Inc.Jobs Report & High Win Rate Trade Alerts - newser.com

07:50 AM
pulisher
07:43 AM

What Fibonacci levels say about Invivyd Inc. rebound2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com

07:43 AM
pulisher
06:15 AM

What candlestick patterns are forming on Invivyd Inc.July 2025 Momentum & Short-Term High Return Strategies - newser.com

06:15 AM
pulisher
06:12 AM

Invivyd (IVVD) Is Up 34.4% After FDA Clears Late-Stage COVID Antibody Program—What’s Changed - Yahoo Finance

06:12 AM
pulisher
04:48 AM

Invivyd (NASDAQ:IVVD) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat

04:48 AM
pulisher
04:26 AM

When is the best time to exit Invivyd Inc.Weekly Profit Analysis & Free Weekly Chart Analysis and Trade Guides - newser.com

04:26 AM
pulisher
03:35 AM

Can Invivyd Inc. rally from current levelsPortfolio Gains Summary & Expert Approved Momentum Ideas - newser.com

03:35 AM
pulisher
02:59 AM

Is Invivyd Inc. stock in correction or buying zoneWeekly Profit Analysis & High Return Stock Watch Alerts - newser.com

02:59 AM
pulisher
02:29 AM

Multi asset correlation models including Invivyd Inc.2025 Macro Impact & Weekly Watchlist for Consistent Profits - newser.com

02:29 AM
pulisher
Oct 07, 2025

Are Investors Undervaluing Invivyd, Inc. (NASDAQ:IVVD) By 31%? - 富途牛牛

Oct 07, 2025
pulisher
Oct 07, 2025

Invivyd (IVVD) Is Up 26.8% After FDA Clears Phase 3 Trials for COVID Antibody Candidate - simplywall.st

Oct 07, 2025
pulisher
Oct 07, 2025

Invivyd (IVVD): Assessing Valuation After FDA Clears Phase 3 COVID-19 Antibody Trial - Yahoo Finance

Oct 07, 2025
pulisher
Oct 06, 2025

D. Boral Capital Maintains Invivyd (IVVD) Buy Recommendation - Nasdaq

Oct 06, 2025
pulisher
Oct 06, 2025

Invivyd receives FDA clearance for COVID antibody prevention trials By Investing.com - Investing.com Nigeria

Oct 06, 2025
pulisher
Oct 06, 2025

D. Boral Capital Increases Invivyd (NASDAQ:IVVD) Price Target to $2.00 - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Invivyd, Inc. Announces U.S. Food and Drug Administration Clearance of Investigational New Drug Application and Provide Feedback to Advance the Company's Revolation Clinical Program - MarketScreener

Oct 06, 2025
pulisher
Oct 06, 2025

New Haven biotech advances vaccine-alternative to prevent COVID - Hartford Business Journal

Oct 06, 2025
pulisher
Oct 06, 2025

Invivyd stock soars after FDA clears IND for COVID antibody candidate - Investing.com

Oct 06, 2025
pulisher
Oct 06, 2025

Cantor Fitzgerald Initiates Invivyd at Overweight With $10 Price Target - MarketScreener

Oct 06, 2025
pulisher
Oct 06, 2025

This Commerce Bancshares Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Oct 06, 2025
pulisher
Oct 06, 2025

Invivyd Shares Climb After FDA Advances Its Covid-Preventing Drug - MarketScreener

Oct 06, 2025
pulisher
Oct 06, 2025

Invivyd, Inc. (NASDAQ:IVVD) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Invivyd (NASDAQ:IVVD) Now Covered by Cantor Fitzgerald - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Invivyd announces IND clearance, alignment with FDA on VYD2311 program - TipRanks

Oct 06, 2025
pulisher
Oct 06, 2025

Invivyd’s VYD2311 Receives FDA Clearance for Trials - TipRanks

Oct 06, 2025
pulisher
Oct 06, 2025

Invivyd receives FDA clearance for COVID antibody prevention trials - Investing.com

Oct 06, 2025
pulisher
Oct 06, 2025

Invivyd gets FDA nod to start key trial of COVID-blocking antibody VYD2311 - MarketScreener

Oct 06, 2025
pulisher
Oct 06, 2025

Invivyd Announces Upcoming Phase 3 Clinical Trials for VYD2311, a Novel COVID Prevention Therapy - Quiver Quantitative

Oct 06, 2025
pulisher
Oct 06, 2025

Invivyd Announces U.S. IND Clearance and Alignment with U.S. FDA on Pivotal Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID - Yahoo Finance

Oct 06, 2025
pulisher
Oct 06, 2025

How supply chain issues affect Invivyd Inc. stockWeekly Gains Summary & High Conviction Trade Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

What to do if you’re stuck in Invivyd Inc.Exit Point & Fast Exit and Entry Trade Guides - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Earnings visualization tools for Invivyd Inc.July 2025 Intraday Action & Daily Profit Focused Screening - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How Invivyd Inc. stock performs in interest rate cyclesGap Down & Weekly Return Optimization Plans - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Why retail investors pile into Invivyd Inc. stockJuly 2025 Outlook & Precise Trade Entry Recommendations - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How moving averages guide Invivyd Inc. tradingPortfolio Performance Summary & Fast Moving Stock Trade Plans - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Is Invivyd Inc. stock safe for conservative investorsWeekly Investment Report & Fast Momentum Entry Tips - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Applying chart zones and confluence areas to Invivyd Inc.2025 Investor Takeaways & Long-Term Safe Investment Plans - newser.com

Oct 02, 2025
pulisher
Sep 29, 2025

Can you recover from losses in Invivyd Inc.2025 Winners & Losers & Growth Focused Stock Pick Reports - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Is Invivyd Inc a good long term investmentVolume Analysis Techniques & Free Double Digit Growth Tips - earlytimes.in

Sep 29, 2025
pulisher
Sep 28, 2025

What analysts say about Invivyd Inc stockStock Rotation Strategies & Small Budget Trading Ideas - earlytimes.in

Sep 28, 2025
pulisher
Sep 26, 2025

Invivyd Appoints New Director Amid Nasdaq Compliance - The Globe and Mail

Sep 26, 2025
pulisher
Sep 25, 2025

Invivyd appoints Wave Life Sciences CEO to board of directors By Investing.com - Investing.com Australia

Sep 25, 2025
$84.68
price down icon 0.81%
$22.62
price down icon 2.91%
$31.65
price down icon 3.15%
$104.08
price down icon 2.07%
$163.81
price up icon 1.16%
biotechnology ONC
$335.16
price down icon 4.48%
大文字化:     |  ボリューム (24 時間):